Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
Status:
Recruiting
Trial end date:
2023-09-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetic, and
pharmacodynamic effects of multiple doses of intravenous DT-216 in adult patients with
Friedrich Ataxia.